("Halma" or "Company")
Halma, the FTSE 100 global group of life-saving technology companies, today announces the following changes:
· Appointment of independent non-executive Director
Liam Condon will be appointed as an independent non-executive Director, with effect from 25 September 2023. Liam will also be a member of Halma's Audit, Remuneration and Nomination Committees.
Liam brings a wealth of experience gained across a variety of roles, with a strong global background in driving growth and sustainability in the Life Science, Chemical and Energy Transition Industries. He is currently Chief Executive of Johnson Matthey plc and earlier in his career, Liam held senior positions within Bayer AG and Schering AG.
There are no further details to be disclosed for Liam Condon under Listing Rule 9.6.13R.
· Retirement of Director and appointment of Senior Independent Director
Tony Rice has informed the Company that, having served for nearly nine years as a non-executive Director, he will step down from the role of Senior Independent Director on 31 July 2023 and retire as a non-executive Director on 31 December 2023.
As part of the Company's succession plans, and following the unanimous support of the Board, Jo Harlow will be appointed as Senior Independent Director with effect from 1 August 2023.
Dame Louise Makin, Chair, commented:
"I am delighted that Liam is joining the Halma Board. He will bring valuable industry insight and international experience to the Board which will help to support Halma's growth ambitions globally.
I would also like to thank Tony for his contribution and support to Halma and the Board over his tenure and congratulate Jo in her new role as Senior Independent Director."
For further information, please contact:
Charles King, Head of Investor Relations
Clayton Hirst, Director of Corporate Affairs
+44 (0)1494 721 111
+44 (0)7834 796 013
A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com